Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2018

Mar 1, 2018

29821_dirs_2018-03-01_858586f2-3db1-45c7-be52-42cf9e5655df.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-02-28

Reporting Person: Nanavaty Maulik (SVP & Pres, Neuromodulation)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-02-28 Common Stock M 3383.0000 $0.0000 Acquired 233220.0000 Direct
2018-02-28 Common Stock M 1629.0000 $0.0000 Acquired 234849.0000 Direct
2018-02-28 Common Stock F 2486.0000 $27.2600 Disposed 232363.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-02-28 Deferred Stock Units $ M 3383.0000 Disposed 2018-02-28 Common Stock (3383.0000) Direct
2018-02-28 Deferred Stock Units $ M 1629.0000 Disposed 2022-02-28 Common Stock (1629.0000) Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.

F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.